874779-56-3

Basic information

• Product Name: Ethyl-4-amino-3-chlorobenzoate
• Synonyms: Ethyl-4-amino-3-chlorobenzoate
• CAS NO: 874779-56-3
• Molecular Formula: C₉H₉BrClNO₂
• Molecular Weight: 199.6342
• Mol File: 874779-56-3.mol
• Article Data: 1

Chemical Properties

• Melting Point: 83-84°C
• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: Ethyl-4-amino-3-chlorobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl-4-amino-3-chlorobenzoate(874779-56-3)
• EPA Substance Registry System: Ethyl-4-amino-3-chlorobenzoate(874779-56-3)

Safety Data

• Hazardous Substances Data: 874779-56-3(Hazardous Substances Data)

Usage

Description

Ethyl-4-amino-3-chlorobenzoate is a chemical compound with the molecular formula C9H10ClNO2. It is a derivative of benzoic acid and is commonly used in the production of pharmaceuticals and agricultural chemicals. This white crystalline solid is soluble in organic solvents and is known for its antibacterial properties.

Uses

Used in Pharmaceutical Industry:
Ethyl-4-amino-3-chlorobenzoate is used as an intermediate in the synthesis of various medications for its antibacterial properties, contributing to the development of new drugs to combat bacterial infections.
Used in Agricultural Chemical Industry:
Ethyl-4-amino-3-chlorobenzoate is used as a precursor in the production of pesticides, leveraging its antibacterial characteristics to create effective agents for controlling pests and diseases in agriculture.
It is important to handle Ethyl-4-amino-3-chlorobenzoate with care, as it may be harmful if ingested or inhaled and can cause irritation to the skin and eyes.

Upstream product

• 7149-03-3 ethyl 3-bromo-4-aminobenzoate 

Downstream Products

• 98556-05-9 4-amino-3-bromo-5-chloro-benzaldehyde 
• 910575-87-0 (4-amino-3-bromo-5-chloro-phenyl)-methanol 
• 874779-57-4 4-amino-3-bromo-5-chloro-benzoic acid 

Relevant articles and documents

CGRP ANTAGONISTS, METHOD FOR THE PRODUCTION THEREOF, AND THEIR USE AS MEDICAMENTS

The invention relates to CGRP antagonists of general formula (I) in which: R1, R2, R3, R4 and X are defined as in Claim 1, to their tautomers, isomers, diastereomers, enantiomers, hydrates, mixtures and salts as well as the hydrates of the salts, in particular, their physiologically compatible salts with inorganic or organic acids and bases, and those compounds of general formula (I) in which one or more hydrogen atoms are replaced by deuterium. The invention also relates to medicaments containing these compounds, the use thereof, and to methods for producing them.